GlaxoSmithKline Pharmaceuticals Limited
₹2,457.15
INR+4.45(+0.18%)
As of November 14, 2024 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹45305.00 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹42709.70 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
66.91
Forward P/E
Price to Earnings ratio based on forecasted earnings
48.71
PEG Ratio
Price/Earnings to Growth ratio
48.71
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
12.92
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
63.75%
Operating Margin
Operating income as a percentage of revenue
26.28%
Return on Equity
Net income as a percentage of shareholders' equity
33.19%
Revenue (TTM)
Total revenue over trailing 12 months
₹3506.70 Cr+7.000000000000001%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹1067.48 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹39.97+37.9%
Balance Sheet
Total Cash
Total cash and short-term investments
₹1856.82 Cr
Total Debt
Total short-term and long-term debt
₹18.66 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
1.05%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹1385.05 - ₹3088
Beta
Measure of stock's volatility compared to the market
0.22
Shares Outstanding
Total number of shares issued by the company
₹16.94 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
4.72%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.00%
Payout Ratio
Percentage of earnings paid as dividends
84.70%